Aktuellt
SENASTE
Redeye retains its positive view of Avensia despite a soft Q2, with sales and EBIT below our expectations. Although Q2 was hurt by low utilization, Avensia experienced a gradual improvement during the quarter thanks to personnel reductions and a stabilized market. While we somewhat cut our forecast and Base Case, we still expect significant margin improvements mid-term, and we believe the case is intact.
LÄS MER
